Perkins Coie Adds Leading Life Sciences Lawyer to Emerging Companies & Venture Capital Practice in San Diego

Perkins Coie is pleased to announce that Stephen C. Ferruolo, a leading life sciences lawyer, has joined the firm’s Emerging Companies & Venture Capital (ECVC) practice as a partner in the San Diego office.

Ferruolo will focus his practice on the life sciences sector, representing private and publicly held biotech, pharmaceutical, medical device and digital health companies, as well as technology companies, investors, and venture capitalists.

His focus will also include guiding clients through private and public financings as well as mergers and acquisitions, corporate governance issues, licensing, collaboration and commercial agreements, and compliance matters. Ferruolo has worked on hundreds of private financings during his legal career, with a broad range of venture capitalists and other investors and handled IPOs ranging from $6 million to $1.1 billion.

Ferruolo most recently served as the dean of the University of San Diego School of Law, where he was also a professor of law in business and corporate law, contracts, and securities regulation. Prior to that, he held a variety of senior law firm positions in Southern California, including with Goodwin Proctor LLP and Heller Ehrman LLP, and he currently serves on the board of directors of BIOCOM, the largest regional life sciences association in the world.

Ferruolo earned his B.A., magna cum laude, from Wesleyan University and his J.D. from Stanford University Law School. He also earned an M.A. and Ph.D. in History from Princeton University and was a Rhodes Scholar at Oxford University, where he earned an M.Phil. in Medieval European History.